Physician

Laura Paul Fite, M.D.

According to 2025 Medicare claims, Laura Fite, M.D. (NPI: 1861750416) practices dermatology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is WALLIS DERMATOLOGY ASSOCIATES PLLC (NPI: 1396945234; TIN: 454041922) and primary practice location at 75605-0038.

Fite's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 981 traditional Medicare patients, billed 7,661 HCPCS/CPT codes, and received $349,431 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,684 prescription claims across 593 beneficiaries totaling $1,097,410 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 122 records totaling $2,189. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $38,471 to $349,431. Similarly, Part D prescription costs have risen steadily, from $51,786 to $1,097,410. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	267	890	$38,471
2018	892	3,054	$139,012
2019	629	3,173	$125,872
2020	665	4,613	$145,932
2021	646	5,675	$159,097
2022	764	5,108	$189,253
2023	954	7,540	$267,232
2024	981	7,661	$349,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	20	33	$51,786
2016	11	22	$1,241
2017	95	183	$32,142
2018	451	932	$104,682
2019	403	1,133	$332,586
2020	350	1,164	$269,697
2021	323	1,000	$478,582
2022	398	1,101	$529,629
2023	513	1,447	$1,122,162
2024	593	1,684	$1,097,410

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	233	277	$72
11102	Biopsy of related skin growth, first growth	148	165	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	647	915	$56
17000	Destruction of precancer skin growth, 1 growth	346	466	$37
17003	Destruction of precancer skin growth, 2-14 growths	260	1,338	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	42	1,176	$487,498
Dupixent Pen	Dupilumab	31	868	$114,081
Rinvoq	Upadacitinib	14	420	$92,470
Opzelura	Ruxolitinib Phosphate	11	330	$21,416
Clobetasol Propionate	Clobetasol Propionate	146	3,651	$4,953

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	122	$2,189	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura Paul Fite, M.D.?

Tedicare shows public-source Medicare data for Laura Paul Fite, M.D. (NPI 1861750416), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Paul Fite, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura Paul Fite, M.D.?

Laura Paul Fite, M.D. is linked to WALLIS DERMATOLOGY ASSOCIATES PLLC (billing NPI 1396945234) in the available physician profile data.

Does Laura Paul Fite, M.D. have Open Payments data?

Laura Paul Fite, M.D. has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.